How Has the Vitamin D Therapy Market Evolved Historically and What is its Current Size?
The vitamin d therapy market has seen considerable growth due to a variety of factors.
• The size of the vitamin D therapy market has seen a swift expansion in the last few years, surging from $2.92 billion in 2024 to an anticipated $3.27 billion in 2025. This constitutes a compound annual growth rate (CAGR) of 12.1%. Several factors have fueled this growth during the historical period, including an elevated awareness of Vitamin D deficiency, a rise in bone disorder incidents, an ageing demographic, prevalent osteoporosis, the highlighting of benefits through scientific investigation, an upturn in diseases related to lifestyle habits, and medical guidance promoting supplementation.
What Is The Projected Growth Of The Vitamin D Therapy Market Size?
The Vitamin D Therapy market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to witness accelerated growth in the approaching years, the vitamin D therapy market is estimated to expand to $5.44 billion by 2029 with a compound annual growth rate (CAGR) of 13.6%.
This growth during the predicted period can be ascribed to ongoing awareness and educational initiatives, a growing senior citizen population, vitamin D's incorporation in the treatment of chronic illnesses, advancements in formulation technologies, worldwide health campaigns, and a heightened emphasis on individual nutrition. The upcoming period's key trends encompass broadening uses beyond supporting bone health, governmental programs endorsing supplementation, breakthroughs in formulation and delivery techniques, a shift towards clinical research and evidence-based practices, along with the global market's expansion.
What Are The Key Drivers Fueling Growth In The Vitamin D Therapy Market?
The projected rise in malnutrition cases is likely to fuel the expansion of the vitamin D therapy market. Malnutrition is characterized by inadequate or excessive nutrient intake, nutrient imbalances, or hindered nutrient utilization. It is found that vitamin D deficiency is extremely common in hospitalized malnourished patients and is inversely related to long-term mortality, especially when patients are not undergoing vitamin D therapy. Consequently, the growing occurrence of malnutrition cases necessitates vitamin D therapy. For instance, the World Health Organization, a Switzerland-based health-promoting, global safety, and vulnerability-serving agency, reported in March 2024 that in 2022, about 390 million adults globally aged 18 years and older were underweight, while 2.5 billion were overweight, including 890 million who were obese. Among children and adolescents aged between 5-19 years, 390 million were overweight, including 160 million who were obese. Additionally, 190 million were thin, and an estimated 149 million children below the age of 5 years were stunted, while 37 million were overweight or obese. Almost half of the deaths among children below 5 years of age are attributed to undernutrition. Hence, the surge in malnutrition cases is stimulating the growth of the vitamin D therapy market.
What Are The Principal Market Segments In The Global Vitamin D Therapy Industry?
The vitamin d therapy market covered in this report is segmented –
1) By Administration: Oral, Parenteral
2) By Purchasing: OTC Drugs, Prescription Drugs
3) By Age Group: Children, Adults, Senior Adults
4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders
Subsegments:
1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages
2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations
Pre-Book The Vitamin D Therapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Vitamin D Therapy Industry?
A trend that is currently gaining traction in the vitamin D therapy market is product innovation. To maintain their market positions, major firms in this sector are rolling out inventive products. For instance, Cadila Pharmaceuticals Pvt Ltd., a multinational pharmaceutical company based in India, set a new precedent in Vitamin D deficiency therapy with the debut of its first aqueous formulation in February 2024, aptly named Aqueous Cholecalciferol Injection by Cadila Pharmaceuticals. This cutting-edge innovation offers a quick fix for Vitamin D deficiency in a short duration and boasts superior pharmacokinetics (PK) and pharmacodynamics (PD) compared to the conventional oil-based cholecalciferol preparations available in the market.
Who Are the Key Players In The Vitamin D Therapy Market?
Major companies operating in the vitamin d therapy market include:
• Abbott Laboratories
• Sanofi SA
• GlaxoSmithKline PLC
• Pfizer Inc.
• Merck & Co Inc.
• Torrent Pharmaceuticals Ltd.
• Novartis International AG
• Alkem Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• Cadila Healthcare Ltd.
• Biotics Research Corporation
• Solvay Pharma India Pvt. Ltd.
• Forgo Pharmaceuticals Ltd.
• Mankind Pharmaceuticals Pvt. Ltd.
• Cipla Ltd.
• Ortho Molecular Products
• Zhejiang Garden Biochemical High-tech Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Dr. Reddy's Laboratories Ltd.
• Emcure Pharmaceuticals Ltd.
• Intas Pharmaceuticals Ltd.
• Lupin Ltd.
• Macleods Pharmaceuticals Ltd.
• Mylan N.V.
• Sunovion Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• Biocare Medical LLC
• Mitsubishi Chemical Group
• Zydus Cadila
• DSM Nutritional Products AG
• BASF SE
• Fermenta Biotech Ltd.
• Taizhou Hisound Pharmaceutical Co. Ltd.
What Are The Regional Insights Into The Vitamin D Therapy Market?
North America was the largest region in the vitamin D therapy market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin D therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
